martes, 6 de octubre de 2026
BuscarExplore
es.VIA.NEWS
Via News Knowledge File

Elf Labs

organization80% conf.·synced Aug 13, 2026

IP-focused entertainment company controlling 500+ trademarks/copyrights for characters including Cinderella, Snow White, Rapunzel, Sleeping Beauty, and Peter Pan; over $15M in royalties

31
sourced metrics
0
relationships
18
stated objectives
0
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Country Licensing
30count
source
Trademarks Copyrights Owned
500assets
source
Countries Licensed
30count
⚠ sources conflictsource
Country Count
30countries
⚠ sources conflictsource
Country Expansion
30count
source
Country Presence
30countries
source
Distribution Countries
30countries
source
Geographic Reach
30countries
source
Intellectual Property
500trademarks_and_copyrights
source
Intellectual Property Count
500trademarks_copyrights
⚠ sources conflictsource
International Markets
30countries
source
Ip Assets
500trademarks_and_copyrights
source
Licensing Countries
30countries
⚠ sources conflictsource
Licensing Markets
30countries
source
Market Cap
1600USD
⚠ sources conflictsource
Market Expansion
30countries
source
Market Presence
30countries
source
Product Count
100product_lines
source

Stated objectives

Expand investor base through Regulation A+ offering at $0.85/share with $1,000 minimum investment to diversify portfolios into early-stage AI innovation

source
target: 0.85 per share stated

Scale AI marketing platform to help transform data chaos into actionable insights and create high-performing content with measurable ROI

source
stated

Generate measurable ROI for clients through AI-driven content creation and data analytics

source
stated

Provide investors exposure to rapidly growing AI and tech sector at ground-floor stage

source
target: 0.85 per share minimum investment of 1000 USD stated

Elf Labs scaling distribution through patented production systems, global licensing, and streaming and mobile initiatives toward public market listing

source
target: Nasdaq listing under ticker ELFS stated

Scaling distribution through patented production systems, global licensing, and streaming and mobile initiatives

source
stated

Scale distribution through patented production systems, global licensing, and streaming and mobile initiatives toward public market listing on Nasdaq

source
stated

Scaling distribution through patented production systems, global licensing, and streaming and mobile initiatives

source
stated

Scale distribution through patented production systems, global licensing, streaming and mobile initiatives toward public market transition

source
stated

Scale distribution through patented production systems, global licensing, streaming and mobile initiatives toward public market debut

source
stated
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Nuestra lectura de los datos ›
Señales que seguimos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,985
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,985 hechos verificados con la fuente5,351 documentos fuente archivados
Consulta estos datos → isubstrate.com